Acrivon Therapeutics, Inc. ACRV Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS-$0.51Beat by $0.06
EPS estimate-$0.57
Next report
Aug 12, 2026 (In 2 weeks)Revenue estimate$386.3K
EPS estimate-$0.49
Versus estimates
Diluted EPS
Ask the moment Acrivon Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Acrivon Therapeutics, Inc. report Q1 2025 earnings?
- Acrivon Therapeutics, Inc. (ACRV) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Acrivon Therapeutics, Inc.'s Q1 2025 revenue and EPS?
- Acrivon Therapeutics, Inc. reported eps of $-0.51 for Q1 2025.
- Did Acrivon Therapeutics, Inc. beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-0.57 by $0.06.
- How did Acrivon Therapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 30.1% from $-0.73.
- Where can I find Acrivon Therapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-071427) directly on SEC EDGAR. The filing index links above go to sec.gov.